Hydantoin-substituted 4,6-dichloroindole-2-carboxylic acids as ligands with high affinity for the glycine binding site of the NMDA receptor.
暂无分享,去创建一个
Wolfgang Löscher | Heidrun Potschka | W. Löscher | M. Jansen | C. Brandt | H. Potschka | Michaela Jansen | Claudia Brandt | Gerd Dannhardt | G. Dannhardt
[1] L. Iversen,et al. The glycine site on the NMDA receptor: structure-activity relationships and therapeutic potential. , 1994, Journal of medicinal chemistry.
[2] R. Di Fabio,et al. Unusual synthesis of new glycine antagonists via sequential aldol condensation-lactonization-elimination reaction. , 1998, Bioorganic & medicinal chemistry letters.
[3] A. Avdeef,et al. PH-metric log P 11. pKa determination of water-insoluble drugs in organic solvent-water mixtures. , 1999, Journal of pharmaceutical and biomedical analysis.
[4] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[5] A. Leo,et al. Hydrophobicity and central nervous system agents: on the principle of minimal hydrophobicity in drug design. , 1987, Journal of pharmaceutical sciences.
[6] J. Olney,et al. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. , 1989, Science.
[7] J. Hawkinson,et al. Subtype-selective N-methyl-D-aspartate receptor antagonists: synthesis and biological evaluation of 1-(arylalkynyl)-4-benzylpiperidines. , 1999, Journal of medicinal chemistry.
[8] F. Salituro,et al. 3-(2-carboxyindol-3-yl)propionic acid derivatives: antagonists of the strychnine-insensitive glycine receptor associated with the N-methyl-D-aspartate receptor complex. , 1990, Journal of medicinal chemistry.
[9] W. Löscher,et al. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. IV. Protective indices , 1991, Epilepsy Research.
[10] J. Massagué. TGF-beta signal transduction. , 1998, Annual review of biochemistry.
[11] G. Höfner,et al. 5‐Arylidene‐3‐aryl‐pyrrolidine‐2,4‐diones with Affinity to the N‐Methyl‐D‐aspartate (Glycine Site) Receptor, Part I , 1998, Archiv der Pharmazie.
[12] W. Löscher,et al. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. I. The influence of administration vehicles , 1990, Epilepsy Research.
[13] B. Harrison,et al. [3H]5,7-dichlorokynurenic acid, a novel radioligand labels NMDA receptor-associated glycine binding sites. , 1991, European journal of pharmacology.
[14] A. Reggiani,et al. Substituted analogues of GV150526 as potent glycine binding site antagonists in animal models of cerebral ischemia. , 1999, Journal of medicinal chemistry.
[15] B. D. Harris,et al. Reductive Amination of Aldehydes and Ketones with Sodium Triacetoxyborohydride. Studies on Direct and Indirect Reductive Amination Procedures. , 1996 .
[16] W. Löscher,et al. New visions in the pharmacology of anticonvulsion. , 1998, European journal of pharmacology.
[17] G. Höfner,et al. Characterisation of the binding of [3H]MDL 105,519, a radiolabelled antagonist for the N-methyl-d-aspartate-associated glycine site, to pig cortical brain membranes , 1997, Neuroscience Letters.
[18] D. Butterfield,et al. Amyloid β Peptide (25–35) Inhibits Na+‐Dependent Glutamate Uptake in Rat Hippocampal Astrocyte Cultures , 1996, Journal of neurochemistry.
[19] B. Harrison,et al. [3H]MDL 105,519, a high-affinity radioligand for the N-methyl-D-aspartate receptor-associated glycine recognition site. , 1996, The Journal of pharmacology and experimental therapeutics.
[20] G. Dannhardt,et al. The NMDA receptor complex: a promising target for novel antiepileptic strategies. , 2001, Current medicinal chemistry.
[21] G. Tarzia. (E)‐3‐(2‐(N‐Phenylcarbamoyl)vinyl)pyrrole‐2‐carboxylic Acid Derivatives. A Novel Class of Glycine Site Antagonists. , 1998 .
[22] B. Meldrum,et al. Anticonvulsant action of excitatory amino acid antagonists. , 1982, Science.
[23] A. Capelli,et al. Substituted indole-2-carboxylates as in vivo potent antagonists acting as the strychnine-insensitive glycine binding site. , 1997, Journal of medicinal chemistry.
[24] P. Leeson,et al. 4-Amido-2-carboxytetrahydroquinolines. Structure-activity relationships for antagonism at the glycine site of the NMDA receptor. , 1992, Journal of medicinal chemistry.
[25] B. Meldrum,et al. Na+ channels as targets for neuroprotective drugs. , 1995, Trends in pharmacological sciences.
[26] J. Kemp,et al. 4-substituted-3-phenylquinolin-2(1H)-ones: acidic and nonacidic glycine site N-methyl-D-aspartate antagonists with in vivo activity. , 1997, Journal of medicinal chemistry.
[27] E. Mohr,et al. Huntington's disease: pathogenesis, diagnosis and treatment. , 1994, Journal of psychiatry & neuroscience : JPN.
[28] W. Löscher. Animal Models of Epilepsy and Epileptic Seizures , 1999 .
[29] Y. Cheng,et al. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.
[30] S. Espitia,et al. Subtype-selective N-methyl-D-aspartate receptor antagonists: synthesis and biological evaluation of 1-(heteroarylalkynyl)-4-benzylpiperidines. , 2001, Journal of medicinal chemistry.
[31] G. Dannhardt,et al. The glycine site on the NMDA receptor: structure-activity relationships and possible therapeutic applications. , 1998, Current medicinal chemistry.
[32] G. Dannhardt,et al. Benzimidazoles as NMDA Glycine‐Site Antagonists: Study on the Structural Requirements in 2‐Position of the Ligand , 2000, Archiv der Pharmazie.
[33] W. Catterall,et al. Binding of batrachotoxinin A 20-alpha-benzoate to a receptor site associated with sodium channels in synaptic nerve ending particles. , 1981, The Journal of biological chemistry.
[34] C. Becker,et al. The inhibitory glycine receptor: prospects for a therapeutic orphan? , 1998, Current pharmaceutical design.
[35] B. D. Harris,et al. Reductive Amination of Aldehydes and Ketones with Sodium Triacetoxyborohydride. Studies on Direct and Indirect Reductive Amination Procedures(1). , 1996, The Journal of organic chemistry.
[36] G. Höfner,et al. Characterisation of [3H]MK-801 binding and its cooperative modulation by pig brain membranes. , 1996, Journal of receptor and signal transduction research.
[37] C. Arias,et al. β‐Amyloid peptide fragment 25–35 potentiates the calcium‐dependent release of excitatory amino acids from depolarized hippocampal slices , 1995, Journal of neuroscience research.
[38] H. White. Comparative Anticonvulsant and Mechanistic Profile of the Established and Newer Antiepileptic Drugs , 1999, Epilepsia.
[39] M. Mattson,et al. beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[40] K. Lange,et al. Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-Dopa in models of Parkinson's disease , 1991, Journal of neural transmission. Parkinson's disease and dementia section.
[41] W. Löscher,et al. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models , 1991, Epilepsy Research.
[42] A. Ganesan,et al. Solution-Phase Synthesis of a Combinatorial Thiohydantoin Library(1). , 1997, The Journal of organic chemistry.
[43] J. Monahan,et al. Novel indole-2-carboxylates as ligands for the strychnine-insensitive N-methyl-D-aspartate-linked glycine receptor. , 1991, Journal of medicinal chemistry.
[44] P. Krogsgaard‐Larsen,et al. Ligands for Glutamate Receptors: Design and Therapeutic Prospects , 2000 .
[45] P D Leeson,et al. Effect of plasma protein binding on in vivo activity and brain penetration of glycine/NMDA receptor antagonists. , 1997, Journal of medicinal chemistry.
[46] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.
[47] M. Baudry,et al. [3H]Dizocilpine Association Kinetics Distinguish Stimulatory and Inhibitory Polyamine Sites of N‐Methyl‐d‐Aspartate Receptors , 1994, Journal of neurochemistry.